跳至主要内容
临床试验/NCT04846543
NCT04846543招募中不适用

PMCF Study - Verification of Activa IM-Nail™ Safety and Clinical Performance

Thomas Klestil17 个研究点 分布在 7 个国家目标入组 220 人开始时间: 2021年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
220
试验地点
17
主要终点
Refracture rate

研究概览

简要总结

The Activa IM-Nail™ is used in the fixation of forearm fractures with cast to achieve a level of reduction and stabilisation that is appropriate to the age of the child. The post-market clinical follow-up study will be performed to identify the residual risk related to re-fracture and to determine its impact to the risk/benefit ratio of Activa IM-Nail™.

详细描述

Residual risk related to re-fracture rate will be addressed by this PMCF study. The research question is, if the re-fracture risk with Activa IM-nail is in line with the other treatment methods, namely ESIN.

Primary objective: will be to assess clinical outcome by determining re-fracture rate of all treated patients, difference of re-fracture rate depending on the fracture type determined by X-ray (e.g. greenstick vs. non-greenstick fracture), subject's age, BMI, surgical technique, immobilization time and bony union formation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Diaphyseal forearm fractures (radius or ulna or both)
  • Patients from 3 years to under 13 years, but the age limits depend on the biological development of the child and in addition

排除标准

  • multifragmentary fractures, metaphyseal and epiphyseal fractures
  • Situations where internal fixation is otherwise contraindicated, e.g., active or potential infection, or where a patient's cooperation cannot be guaranteed.

结局指标

主要结局

Refracture rate

时间窗: First year after operation

Assessment of refracture rate

次要结局

  • Absorption of implant(One and two years after operation)
  • Bony union(One year after operation)
  • Monteggia lesion and equivalent(2 years after operation)
  • Cost effectiveness(1 year after operation)

研究者

发起方
Thomas Klestil
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Thomas Klestil

Univ.-Prof. DDr. Thomas Klestil

Danube University Krems

研究点 (17)

Loading locations...

相似试验